Medical Equipment

Projected Growth of the Global Oncology Biomarkers Market to Reach $29.39 Billion by 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the oncology biomarkers market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Oncology Biomarkers Market By The End Of 2029?

The oncology biomarkers market has experienced rapid expansion over recent years. Projections indicate it will expand from $15.3 billion in 2024 to reach $17.3 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 13.0%. Historically, its growth has been driven by factors such as adoption in emerging economies, precision medicine initiatives, diagnostic innovations, drug development support, and increased cancer incidence.

The oncology biomarkers market size is projected to experience substantial growth over the coming years, with its value expected to reach $29.39 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 14.2%. This anticipated expansion during the forecast period can be attributed to several factors, including the integration of next-generation sequencing (ngs), the growth of biomarker informatics, a focus on predictive pharmacogenomics, the swift progress in exosome-based biomarkers, and the adoption of spatial transcriptomics. Key trends for this period encompass standardization and quality assurance, a move towards functional biomarkers, the significant role of biomarkers in clinical trials, broadening applications in immunotherapy, and real-time monitoring of treatment responses.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12493&type=smp

Which Business Drivers Are Underpinning The Growth Of The Oncology Biomarkers Market?

The increasing occurrence of cancer is projected to propel the expansion of the oncology biomarker market moving forward. Cancer is a condition where certain body cells grow uncontrollably and gradually spread throughout the body. Oncological biomarkers provide more detailed information about the cancer type by analyzing genes, proteins, and other substances within a person’s body. For instance, in January 2024, the National Library of Medicine, a US-based government institution, indicated that 2,001,140 new cancer cases and 611,720 cancer-related deaths are anticipated in the United States during 2024. Additionally, among young adults, the incidence rates for cervical cancer in individuals aged 30 to 44 and colorectal cancer in those under 55 have been increasing by 1% to 2% annually. Consequently, the escalating incidence of cancer will drive the oncology biomarker market.

What Are The Principal Segment Types In The Oncology Biomarkers Market?

The oncology biomarkersmarket covered in this report is segmented –

1) By Biomarker Type: Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers

2) By Profiling Technologies: Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Other Profiling Technologies

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Leukemia, Ovarian Cancer, Liver Cancer, Other Cancer Types

4) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications

5) By End-User: Hospitals, Academic And Cancer Research Institutes, Ambulatory Surgical Centers, Diagnostic Laboratories

Subsegments:

1) By Protein Biomarkers: Tumor-Specific Antigens, Circulating Tumor Cells (CTCs), Enzymatic Biomarkers

2) By Genetic Biomarkers: DNA Mutations, Gene Expression Profiles, Single Nucleotide Polymorphisms (SNPs)

3) By Other Cancer Biomarkers: Metabolomic Biomarkers, Epigenetic Biomarkers, MicroRNA Biomarkers

How Are Industry Trends Steering The Expansion Of The Oncology Biomarkers Market?

A significant trend in the oncology biomarker market involves the adoption of innovative and advanced technologies. Major companies within the oncology biomarkers market are launching new and innovative technologies to enhance their market standing. For instance, in 2022, OncoDNA, a Belgium-based company focused on precision medicine in oncology, introduced OncoDEEP, a distinctive kit that allows laboratories to conduct comprehensive biomarker testing. OncoDEEP incorporates Next-generation sequencing (NGS) technology and cloud-based software tools, providing laboratories with the capability to perform large-panel sequencing, obtain the molecular characterization of a tumor, analyze the raw data, and access extensive quality controls.

Which Companies Are Contributing Significantly To The Oncology Biomarkers Market Growth?

Major companies operating in the oncology biomarkers market include F Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Eli Lilly and Company, Merck KGaA, Siemens Healthcare GmbH, Becton Dickinson and Company, GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Charles River Laboratories International Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Exact Sciences Corporation, Sysmex Corporation, PerkinElmer Inc., Leica Biosystems, Myriad Genetics Inc., Guardant Health Inc., Enzo Biochem Inc., Biocartis Group NV, Bristol -Myers Squibb Company, Agendia Inc., Epigenomics AG, OncoDNA SA

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/oncology-biomarkers-global-market-report

Which Region Offers The Most Opportunity For Oncology Biomarkers Market Expansion?

North America was the largest region in the oncology biomarkers market in 2024. The regions covered in the oncology biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=12493&type=smp

Browse Through More Reports Similar to the Global Oncology Biomarkers Market 2025, By The Business Research Company

Immuno Oncology Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report

Interventional Oncology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Oncology Biosimilar Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795